ALBT - יחס מחיר להכנסות חזויות Avalon GloboCare Corp

The lack of recurring revenue due to a focus on regenerative medicine makes Avalon GloboCare (ALBT) stock dynamics dependent on external funding, and by tracking the business's future P/S on GURU.Markets, we note that the indicator value reaches 3.90. Avalon GloboCare (ALBT) management effectively combines clinical expertise with corporate governance. The holding company has currently paused mergers to monetize its existing laboratory networks.
פילוחים אנליטיים ודוחות נתונים של חברת Avalon GloboCare Corp (ALBT)

The forward P/S reflects the ratio of Avalon GloboCare (ALBT) market capitalization to projected annual revenue, where the projected P/S trend allows for an assessment of the premium paid for expected cash flows. A high multiple here is justified by the inelastic demand for the unique QTY protein code, which provides the company with pricing power and fundamental business stability during its expansion into cancer therapy.